EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

An NDM-Producing Escherichia coli Clinical Isolate Exhibiting Resistance to Cefiderocol and the Combination of Ceftazidime-Avibactam and Aztreonam: Another Step Toward Pan-β-Lactam Resistance

Patricia J Simner, Yehudit Bergman, Rick Conzemius, Emily Jacobs, Tsigereda Tekle, Stephan Beisken, Pranita D Tamma iD

Open Forum Infectious Diseases · 01.07.2023 · 10 (7)

DOI: 10.1093/ofid/ofad276 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 17.05.2023. Verfasst von Patricia J Simner und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Die Arbeit wurde bisher 80-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Institutes of Health, grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cefiderocol and ceftazidime-avibactam plus aztreonam (CZA-ATM) are preferred treatment regimens for New Delhi metallo-β-lactamase (NDM)-producing infections.

Methods

We report the case of a US patient who traveled to India to receive a renal transplant. He subsequently experienced pyelonephritis by an NDM-producing Escherichia coli. Broth microdilution and the broth disk elution method indicated resistance to all β-lactams, including cefiderocol and CZA-ATM. Whole-genome sequencing investigations were undertaken to identify resistance mechanisms.

Results

An E. coli isolate belonging to sequence type (ST) 167 containing a blaNDM-5 gene was identified on a plasmid of the IncFIA/IncFIB/IncFIC replicon groups. When compared with the genome of another ST167 E. coli clinical isolate containing blaNDM-5 and exhibiting susceptibility to cefiderocol and CZA-ATM, a 12–base pair insertion in ftsI, translating to a 4–amino acid duplication in PBP3, was identified. Moreover, a blaCMY-59 gene was harbored on an IncI-γ replicon type, and frameshift mutations were identified in the cirA iron transport gene.

Conclusions

This is the first clinical case of a US patient harboring an NDM-producing isolate exhibiting resistance to all available β-lactam agents. The isolate's unexpected resistance to cefiderocol and CZA-ATM was likely due to a combination of (1) a modified PBP3 (increased MICs to both regimens), (2) truncated iron-binding protein (increased cefiderocol MIC), and (3) a blaCMY gene (reduced CZA-ATM activity). E. coli ST167 clinical isolates harboring blaNDM-5 genes are a recognized international high-risk clone. When coupled with the additional mechanisms identified in our patient's isolate, which is not uncommon for this high-risk clone, pan-β-lactam resistance may occur.

Schlagwörter

Stichwörter der Autor:innen

PBP3antimicrobial resistanceaztreonamcefiderocolceftazidime-avibactam

Autor:innen und Institutionen

  • Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Ares Genetics, Vienna, Austria.
  • Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

ORCID-Profile: Pranita D Tamma

Förderung

  • National Institutes of Health
  • grant

Zitieren

APA

Simner, P. J., Bergman, Y., Conzemius, R., Jacobs, E., Tekle, T., Beisken, S., & Tamma, P. D. (2023). An NDM-Producing Escherichia coli Clinical Isolate Exhibiting Resistance to Cefiderocol and the Combination of Ceftazidime-Avibactam and Aztreonam: Another Step Toward Pan-β-Lactam Resistance. Open Forum Infectious Diseases, 10(7). https://doi.org/10.1093/ofid/ofad276

Vancouver

Simner PJ, Bergman Y, Conzemius R, Jacobs E, Tekle T, Beisken S, et al. An NDM-Producing Escherichia coli Clinical Isolate Exhibiting Resistance to Cefiderocol and the Combination of Ceftazidime-Avibactam and Aztreonam: Another Step Toward Pan-β-Lactam Resistance. Open Forum Infectious Diseases. 2023;10(7). doi:10.1093/ofid/ofad276

BibTeX
@article{Simner2023,
  author = {Simner, Patricia J and Bergman, Yehudit and Conzemius, Rick and Jacobs, Emily and Tekle, Tsigereda and Beisken, Stephan and Tamma, Pranita D},
  title = {An NDM-Producing Escherichia coli Clinical Isolate Exhibiting Resistance to Cefiderocol and the Combination of Ceftazidime-Avibactam and Aztreonam: Another Step Toward Pan-β-Lactam Resistance},
  journal = {Open Forum Infectious Diseases},
  year = {2023},
  volume = {10},
  number = {7},
  doi = {10.1093/ofid/ofad276}
}
Kostenlos starten →